These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22567190)

  • 1. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
    Torres AG; Threlfall RN; Gait MJ
    Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.
    Fabani MM; Gait MJ
    RNA; 2008 Feb; 14(2):336-46. PubMed ID: 18073344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.
    Torres AG; Fabani MM; Vigorito E; Gait MJ
    RNA; 2011 May; 17(5):933-43. PubMed ID: 21441346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.
    Torres AG; Fabani MM; Vigorito E; Williams D; Al-Obaidi N; Wojciechowski F; Hudson RH; Seitz O; Gait MJ
    Nucleic Acids Res; 2012 Mar; 40(5):2152-67. PubMed ID: 22070883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
    Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).
    Nulf CJ; Corey D
    Nucleic Acids Res; 2004; 32(13):3792-8. PubMed ID: 15263060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
    Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
    Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct comparison of anti-microRNA oligonucleotide potency.
    Lennox KA; Behlke MA
    Pharm Res; 2010 Sep; 27(9):1788-99. PubMed ID: 20424893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2'-
    Honcharenko D; Rocha CSJ; Lundin KE; Maity J; Milton S; Tedebark U; Murtola M; Honcharenko M; Slaitas A; Smith CIE; Zain R; Strömberg R
    Nucleic Acid Ther; 2022 Jun; 32(3):221-233. PubMed ID: 35238623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
    Oh SY; Ju Y; Park H
    Mol Cells; 2009 Oct; 28(4):341-5. PubMed ID: 19812898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing.
    Debacker AJ; Sharma VK; Meda Krishnamurthy P; O'Reilly D; Greenhill R; Watts JK
    Biochemistry; 2019 Feb; 58(6):582-589. PubMed ID: 30520300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gymnotic Delivery of LNA Mixmers Targeting Viral SREs Induces HIV-1 mRNA Degradation.
    Hillebrand F; Ostermann PN; Müller L; Degrandi D; Erkelenz S; Widera M; Pfeffer K; Schaal H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
    Liu Y; Braasch DA; Nulf CJ; Corey DR
    Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
    Oh SY; Ju Y; Kim S; Park H
    Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.
    Chen S; Le BT; Chakravarthy M; Kosbar TR; Veedu RN
    Sci Rep; 2019 Apr; 9(1):6078. PubMed ID: 30988454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of crosslinked 2'-OMe RNA duplexes and their application for effective inhibition of miRNA function.
    Abdelhady AM; Hirano Y; Onizuka K; Okamura H; Komatsu Y; Nagatsugi F
    Bioorg Med Chem Lett; 2021 Sep; 48():128257. PubMed ID: 34246752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
    Berthold PR; Shiraishi T; Nielsen PE
    Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.